Corcept Therapeutics Stock Forecast

Buy or Hold candidate since Apr 24, 2026 Gain 99.48%

The Corcept Therapeutics Incorporated stock price fell by -1.47% on the last day (Friday, 10th Jul 2026) from $93.25 to $91.88. During the last trading day the stock fluctuated 3.50% from a day low at $90.02 to a day high of $93.17. The price has risen in 7 of the last 10 days and is up by 8.41% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -122 thousand shares and in total, 1 million shares were bought and sold for approximately $94.63 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 138.25% during the next 3 months and, with a 90% probability hold a price between $209.65 and $230.63 at the end of this 3-month period.

CORT Signals & Forecast

The Corcept Therapeutics Incorporated stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $91.77 and $78.85. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -2.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Tuesday, August 05, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Corcept Therapeutics Incorporated stock

Corcept Therapeutics Incorporated finds support from accumulated volume at $87.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.15 between high and low, or 3.50%. For the last week, the stock has had daily average volatility of 3.32%.

Our recommended stop-loss: $88.06 (-4.16%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 81 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (CORT) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Corcept Therapeutics Incorporated to open at $91.69, and during the day (based on 14 day Average True Range), to move between $90.18 and $93.58, which gives a possible trading interval of +/-$3.40 (+/-3.77%) up or down from last closing price. If Corcept Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 3.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $92.94 (1.15%) than the support at $87.32 (4.96%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Corcept Therapeutics Incorporated stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Corcept Therapeutics Incorporated stock to perform well in the short-term.

Current score: 3.811 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $91.69 ( 0.207%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk